Targeted Stem Cells Expressing TRAIL as a Therapy for Lung Cancer
NCT03298763
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
46
Enrollment
OTHER
Sponsor class
Conditions
Adenocarcinoma of Lung
Interventions
GENETIC:
MSCTRAIL
DRUG:
Placebo
Sponsor
University College, London